ZURA — Zura Bio Income Statement
0.000.00%
Last trade - 00:00- $93.67m
- -$69.62m
- 45
- 44
- 15
- 27
Annual income statement for Zura Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | — | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | — | 0.889 | 2.68 | 62.6 | 55.2 |
| Operating Profit | 0 | -0.889 | -2.68 | -62.6 | -55.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | — | 6.85 | 3.55 | -60.6 | -52.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | — | 6.85 | 3.55 | -60.6 | -52.4 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | — | 6.85 | 3.55 | -60.4 | -52.4 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 0 | 6.85 | 3.55 | -69.2 | -45.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | — | 0.397 | 0.206 | -2.09 | -0.605 |
| Dividends per Share |